Prosiectau (582)
Cardiff University Schools involved in this Project
ZIP transporter antibodies to inhibit zinc-mediated mitosis (01.02.2023 - 30.06.2024)
- Taylor, Kathryn
Zinc Transporter antibody cancer research (01.06.2022 - 30.06.2025)
- Taylor, Kathryn
Zinc transporter antibody - A potential cancer treatment (03.03.2020 - 31.03.2023)
- Taylor, Kathryn
Welsh NRN Life Sciences Health Related Biosciences Workshop (01.08.2017 - 31.01.2018)
- Brancale, Andrea
Welsh NRN life science drug delivery technology workshop (16.02.2015 - 30.09.2015)
- Mcguigan, Christopher
Welsh movement disorder e-Network for patients receiving Rasagiline (01.04.2013 - 31.03.2014)
Welsh Coronavirus Research (W-CoRe): A platform for the discovery of anti-betacoronaviruses agents (15.10.2020 - 31.03.2021)
- Brancale, Andrea
Welsh anti-microbial testing platform (01.06.2015 - 31.12.2018)
- Brancale, Andrea
Visualisation of biocide effect against Salmonella spp (08.11.2010 - 07.12.2010)
- Maillard, Jean-Yves
Visiting Student (01.04.2016 - 31.07.2017)
- Simons, Claire
Virucidal and tuberculodial infections (04.04.2016 - 03.04.2019)
- Maillard, Jean-Yves
Vector-borne emerging diseases: Computer-aided design, synthesis and evaluation of novel antiviral compounds against Chikungunya and Zika viruses (01.12.2016 - 30.11.2019)
- Bassetto, Marcella
Validating and explaining the presenting skills assessment for medics (01.07.2014 - 15.12.2018)
- Smith, Mathew
UV380 Microbial testing (03.10.2016 - 15.12.2016)
- Maillard, Jean-Yves
Utilising permipatch technology for the controlled and targeted delivery of potassium permanganate micro particles to wounds (01.08.2017 - 31.12.2017)
Using biodiversity research as catalyst for community based co-production studies (28.09.2020 - 31.05.2022)
- Baillie, Les
Using 'big data' to assess the quality of prescribing and medicines management for elderly care home residents (03.01.2017 - 02.01.2020)
- Smith, Mathew
Use of the ex-vivo test to evaluate the efficacy of antimicrobial topical formulations (05.12.2011 - 26.12.2011)
- Maillard, Jean-Yves
Use of minimally invasive technology platforms for extraction and delivery of dendritic cell vaccines (01.08.2017 - 31.10.2017)
- Birchall, James
Unlicensed “special” medicines: improving the patients’ experience (01.04.2018 - 15.04.2023)
- Mantzourani, Efi
Understanding the risk of emerging bacterial resistance to topical antibiotics (01.01.2020 - 31.12.2023)
- Maillard, Jean-Yves
Understanding the risk of emerging bacterial resistance to topical antibiotics (01.04.2019 - 31.08.2019)
- Maillard, Jean-Yves
Understanding the resilience of dry environmental microbial biofilms to disinfection (01.10.2018 - 01.04.2022)
- Maillard, Jean-Yves
Understanding the interactions of oxidising agents with macromolecules and microbial cell components (01.07.2008 - 01.07.2011)
- Maillard, Jean-Yves
Understanding the impact of different surfaces on the efficacy of selected wipe products (18.03.2022 - 31.10.2023)
- Maillard, Jean-Yves
Understanding the biomechanics of human skin tissue and micro-disruption of the skin barrier by transdermal delivery systems (TDS), such as the microneedle array device (MD) (01.06.2010 - 31.05.2011)
- Coulman, Sion
Understanding the association between E-cadherin loss and adverse response to endocrine agents in ER+ breast cancer (01.01.2015 - 31.01.2016)
- Hiscox, Stephen
Understanding how formulation parameters influence the performance of novel capsule formulations (01.07.2024 - 30.06.2027)
- Coulman, Sion
Understanding how ageing and the female gender contribute to mitochondrial dysfunction and the development of Alzheimer's disease (01.10.2019 - 31.03.2022)
- Kidd, Emma
Understanding how age and gender influence the development of Alzheimer's disease (01.10.2018 - 30.09.2021)
- Kidd, Emma
Treating progressive multiple sclerosis using a novel neuroprotective and anti-inflammatory approach (01.10.2015 - 15.11.2018)
- Mcguigan, Christopher
Translation of bacterial mediated therapeutic RNAi of solid tumours by demonstrating PARP inhibition in preclinical trials (30.06.2018 - 15.11.2018)
- Brancale, Andrea
-
- Smith, Mathew
Trace amines for restoring blood pressure and organ perfusion in sepsis (01.04.2022 - 31.03.2025)
- Ford, William
Towards validation of an immune suppressor protein from liver fluke as a drug target (01.10.2015 - 30.09.2018)
- Mcguigan, Christopher
Towards the repurposing of existing topical antimicrobials by ligand complexation (01.10.2015 - 25.01.2019)
- Heard, Charles
Towards the commercialisation of dual action mucoadhesive patches to treat periodontal disease (01.02.2017 - 31.01.2018)
- Heard, Charles
Towards devising a therapeutic strategy for patients with RRM2B-related mitochondrial (15.06.2018 - 31.07.2021)
- Mehellou, Youcef
Towards a nanomedicine-based broad-spectrum topical virucidal therapeutic system (01.10.2007 - 31.01.2011)
- Heard, Charles
Towards a magneto-optical sensor for sepsis (01.07.2012 - 26.08.2012)
- Allender, Christopher
To reduce microbial contamination on surfaces and infection by developing novel and effective antimicrobial surfaces (21.01.2019 - 17.03.2022)
- Maillard, Jean-Yves
To provide analytical and microscopy services, analysis of the components of surgical smoke generated by the use of diathermy (01.03.2015 - 30.04.2015)
- Birchall, James
Topical delivery of Melatonin Derivatives (01.06.2009 - 30.09.2009)
- Heard, Charles
To examine the action of R 1507 in a range of breast cancer models reflective of endocrine response and failure (01.09.2008 - 31.03.2010)
- Hutcheson, Iain
To evaluate the in-vitro potential of locally applied antibiotics to cause the development of bacterial resistance (02.01.2018 - 30.09.2018)
- Maillard, Jean-Yves
To embed expertise on the development of novel biochemical reagents to pathogens and exploit this knowledge to develop point-of-care products for the healthcare sector (07.06.2010 - 06.06.2012)
- Baillie, Les
To develop new biocidal products with efficacy particularly against mycobacteria and non-enveloped viruses (01.11.2016 - 31.12.2019)
- Maillard, Jean-Yves
To carry out experiments to investigate the diffusion of budesonide across ocular membranes (01.06.2010 - 31.05.2012)
- Allender, Christopher
Tissue engineering for human healing (12.04.2010 - 13.10.2011)
- Jones, Arwyn
The use of 3D culture to test the efficacy of a novel enzyme for cancer pro-drug therapy (01.02.2016 - 31.07.2016)
- Mcguigan, Christopher
The therapeutic potential of focal adhesion kinase in endocrine-responsive/resistant breast cancer and the HER2+breast cancer subtype (01.11.2010 - 31.07.2012)
- Hiscox, Stephen
The sporicidal activity of phoraid against Bacillus anthracis spores (01.02.2010 - 26.03.2010)
- Baillie, Les
The sporicidal activity of formalin, hydrogen peroxide, peracetic acid and bleach against Bacillus anthracis spores (01.06.2010 - 31.03.2011)
- Baillie, Les
The role of zinc transporters in cellular zinc signalling (01.08.2010 - 19.09.2015)
- Taylor, Kathryn
The role of caveolins in the processing of amyloid precursor protein (01.11.2010 - 29.02.2012)
- Kidd, Emma
The role of bacterial toxins in diabetes (01.07.2007 - 30.06.2010)
- Wann, Kenneth
Therapeutic modulation of C1s/C4A interactions to prevent schizophrenia (01.09.2023 - 30.11.2024)
- Heurich-Sevcenco, Meike
The involvement of lipid raft proteins in the processing of amyloid precursor protein (01.03.2012 - 30.06.2015)
- Kidd, Emma
The influence of altered endocytic protein expression on the predisposition to develop Alzheimer's disease (08.09.2014 - 30.06.2016)
- Kidd, Emma
The identification of B anthracis specific DNA probes (01.02.2015 - 31.10.2015)
- Baillie, Les
The GDNF neurosurgical clinical trial: listening to, and learning from the participant experience (19.10.2020 - 01.03.2023)
- Lane, Emma
The first preclinical analysis for a novel magnetically directed cancer treatment (01.08.2016 - 30.04.2017)
- Brancale, Andrea
The discovery of mitochondrial-targeting nucleotide prodrugs for the treatment of mitochondrial diseases (01.01.2019 - 30.04.2019)
- Mehellou, Youcef
The development of teriparatide loaded microarray system for improved compliance and persistence of the older patient to treat osteoporosis (01.04.2021 - 31.12.2024)
- Birchall, James
The design synthesis and evaluation of novel agents acting in the CNS (27.10.2014 - 08.01.2016)
- Mcguigan, Christopher
The controlled and targeted release of Potassium permanganates from a matrix into an aqueous interface (01.12.2014 - 30.09.2015)
The controlled and targeted delivery of potassium permanganate micro particles to wounds utilising the permipatch technology (01.10.2016 - 30.09.2017)
The contribution of the exosporium of bacillus anthracis to survival (ROLEEXOSPORIUM) (01.11.2007 - 31.12.2010)
- Baillie, Les
The biological evaluation of protide (01.03.2013 - 30.06.2014)
- Mcguigan, Christopher
Testng of the activity of Sanytol disinfectant wipes against Pseudononas aeruginosa (01.09.2014 - 30.09.2014)
- Maillard, Jean-Yves
Testing the virucidal activity of formulations against poliovirus (01.02.2016 - 29.02.2016)
- Maillard, Jean-Yves
Testing the virucidal activity of formulations against poliovirus (01.07.2015 - 31.12.2015)
- Maillard, Jean-Yves
Testing the Efficacy of two wipes based on the ASTM 2967-15 (01.07.2016 - 31.07.2016)
- Maillard, Jean-Yves
Testing the efficacy of pre-wetted sporicidal wipes (01.09.2016 - 31.10.2016)
- Maillard, Jean-Yves
Testing the antimicrobial activity of product (25.09.2017 - 31.12.2017)
- Maillard, Jean-Yves
Testing of the sporicidal activity of wipes against Clostridium difficile (29.04.2013 - 02.06.2013)
- Maillard, Jean-Yves
Testing of the sporicidal activity of "Schulke" wipe against clostridium difficile (01.09.2012 - 14.09.2012)
- Maillard, Jean-Yves
Testing of the sporicidal activity of PDI wipe against clostridium difficile (01.08.2011 - 14.08.2011)
- Maillard, Jean-Yves
Testing of the sporicidal activity of 3 new products against clostridium difficle (16.01.2012 - 31.01.2012)
- Maillard, Jean-Yves
Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (01.03.2009 - 13.01.2010)
- Maillard, Jean-Yves
Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (29.03.2010 - 30.09.2011)
- Maillard, Jean-Yves
Testing of the sporiciadal activity of wipes against clostridium difficile (10.04.2012 - 13.04.2012)
- Maillard, Jean-Yves
Testing of the propensity of OxyBAC F31 RO (1331) to induce/select/trigger/bacterial resistance (01.07.2014 - 21.07.2014)
- Maillard, Jean-Yves
Testing of the propensity of Oxy BAC F31 RO (1331) to induce/select/trigger bacterial resistance (01.12.2014 - 09.02.2015)
- Maillard, Jean-Yves
Testing of the new sporicidal activity of 3 new products against clostridium difficile (30.01.2012 - 29.04.2012)
- Maillard, Jean-Yves
Testing of the efficacy of Byotrol wipes against two bacterial contaminants (14.05.2012 - 31.05.2012)
- Maillard, Jean-Yves
Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (01.09.2012 - 14.09.2012)
- Maillard, Jean-Yves
Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (28.01.2013 - 27.02.2013)
- Maillard, Jean-Yves
Testing of contamination of Alcoblow(r) (01.04.2013 - 14.04.2013)
- Maillard, Jean-Yves
Testing for broad spectrum efficacy of photosensitiser-based formulation (01.01.2020 - 31.07.2022)
- Maillard, Jean-Yves
Testing antimicrobial material acitvity (14.09.2015 - 13.01.2016)
- Maillard, Jean-Yves
Testing a novel chemotherapy delivery system using two dinitrobenzamide mustard prodrugs (01.10.2015 - 30.09.2018)
- Mcguigan, Christopher
Testing a new skin injection device (15.09.2021 - 28.02.2022)
- Birchall, James
Telehealth enabled medicines for care home residents (01.09.2014 - 31.12.2023)
- James, Delyth
Technology Transfer Workshop (15.03.2017 - 31.12.2017)
- Gumbleton, Mark
Targetting zinc signalling to prevent cell division in cancer (01.10.2015 - 30.09.2018)
- Taylor, Kathryn
Targeting zinc signalling to prevent cell division in cancer (01.10.2016 - 30.09.2018)
- Taylor, Kathryn
Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug (01.10.2016 - 15.11.2018)
- Brancale, Andrea
Targeting natural products to counter the challenge of MRSA (01.10.2014 - 30.09.2017)
- Mcguigan, Christopher
Targeting CtIP to sensitise cancer cells to DNA-damaging agents (01.11.2016 - 31.03.2018)
- Brancale, Andrea